Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Progression-Free Survival"" wg kryterium: Temat


Tytuł :
Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspective.
Autorzy :
Liu J; GlaxoSmithKline, Waltham, MA.
Hawkes C; GlaxoSmithKline, Uxbridge, UK.
Walder L; FIECON, London, UK.
Spalding C; FIECON, London, UK.
Travers K; GlaxoSmithKline, Waltham, MA.
Maiese EM; GlaxoSmithKline, Philadelphia, PA.
Hurteau J; GlaxoSmithKline, Waltham, MA.
Pokaż więcej
Źródło :
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2021 Oct; Vol. 27 (10), pp. 1377-1387.
Typ publikacji :
Journal Article
MeSH Terms :
Budgets*
Progression-Free Survival*
Indazoles/*economics
Ovarian Neoplasms/*drug therapy
Ovarian Neoplasms/*pathology
Piperidines/*economics
Poly(ADP-ribose) Polymerase Inhibitors/*economics
Adult ; Aged ; Cost-Benefit Analysis ; Female ; Humans ; Middle Aged ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; United States
Czasopismo naukowe
Tytuł :
Progression-free survival in oncological clinical studies: Assessment time bias and methods for its correction.
Autorzy :
Miltenberger R; Merck Healthcare KGaA, Frankfurter Straße 250, Darmstadt, Hessen, 64293, Germany.; Department of Mathematics and Natural Sciences, University of Applied Sciences Darmstadt, Schöfferstraße 3, Darmstadt, Hessen, 64295, Germany.
Götte H; Merck Healthcare KGaA, Frankfurter Straße 250, Darmstadt, Hessen, 64293, Germany.
Schüler A; Merck Healthcare KGaA, Frankfurter Straße 250, Darmstadt, Hessen, 64293, Germany.
Jahn-Eimermacher A; Department of Mathematics and Natural Sciences, University of Applied Sciences Darmstadt, Schöfferstraße 3, Darmstadt, Hessen, 64295, Germany.
Pokaż więcej
Źródło :
Pharmaceutical statistics [Pharm Stat] 2021 Jul; Vol. 20 (4), pp. 864-878. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Progression-Free Survival*
Bayes Theorem ; Bias ; Disease-Free Survival ; Humans ; Kaplan-Meier Estimate
Czasopismo naukowe
Tytuł :
Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer: A Meta-analysis.
Autorzy :
Dioun S; Columbia University College of Physicians and Surgeons, New York, New York; Duke University Medical Center, Durham, North Carolina; the Herbert Irving Comprehensive Cancer Center, New York, New York; New York Presbyterian Hospital, New York, New York; the Department of Obstetrics and Gynecology, Tokai University, Kanagawa, Japan; and the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, California.
Wu J
Chen L
Kaplan S
Huang Y
Melamed A
Gockley A
St Clair CM
Hou JY
Tergas AI
Khoury-Collado F
Machida H
Mikami M
Matsuo K
Hershman DL
Wright JD
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2021 Aug 01; Vol. 138 (2), pp. 261-271.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Intraoperative Complications*
Progression-Free Survival*
Rupture*
Ovarian Neoplasms/*surgery
Ovary/*injuries
Disease Progression ; Female ; Humans ; Ovarian Neoplasms/mortality ; Survival Rate
Czasopismo naukowe
Tytuł :
Statistical considerations in clinical trial design with event-free survival as the primary efficacy endpoint.
Autorzy :
Xu T; Department of Biometrics, Vertex Pharmaceuticals Inc., Boston, Massachusetts, USA.
Zhang Y; Department of Statistics, University of Connecticut, Storrs, Connecticut, USA.
Goldwasser M; Strategy and Corporate Operations, Prime Medicine, Inc., Cambridge, Massachusetts, USA.
Zhang V; Department of Biometrics, Agios Pharmaceuticals, Inc., Cambridge, Massachusetts, USA.
Pokaż więcej
Źródło :
Pharmaceutical statistics [Pharm Stat] 2021 Jul; Vol. 20 (4), pp. 721-736. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Progression-Free Survival*
Clinical Trials as Topic ; Disease-Free Survival ; Humans
Czasopismo naukowe
Tytuł :
68-months progression-free survival with crizotinib treatment in a patient with metastatic ALK positive lung adenocarcinoma and sarcoidosis: A case report.
Autorzy :
Tanriverdi O; Department of Medical Oncology, Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Tarimer ML; Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Pak CD; Department of Family Medicine, Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Uylas S; Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Alkan A; Department of Medical Oncology, Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Celik OI; Department of Pathology, Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Kilic RM; Department of Radiodiagnostics, Faculty of Medicine, Mugla Sitki, Koçman University, Mugla, Turkey.
Zeybek A; Department of Thoracic Surgery, Faculty of Medicine, Mugla Sitki Koçman University, Mugla, Turkey.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Jun; Vol. 27 (4), pp. 984-989. Date of Electronic Publication: 2020 Aug 23.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anaplastic Lymphoma Kinase*/genetics
Progression-Free Survival*
Adenocarcinoma of Lung/*drug therapy
Crizotinib/*therapeutic use
Lung Neoplasms/*drug therapy
Sarcoidosis/*drug therapy
Adenocarcinoma of Lung/diagnostic imaging ; Adenocarcinoma of Lung/genetics ; Antineoplastic Agents/therapeutic use ; Female ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/genetics ; Middle Aged ; Sarcoidosis/diagnostic imaging ; Sarcoidosis/genetics ; Time Factors
Czasopismo naukowe
Tytuł :
Recurrence- and progression-free survival in intermediate-risk non-muscle-invasive bladder cancer: the impact of conditional evaluation and subclassification.
Autorzy :
Kohada Y; Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Hayashi T; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Hsi RS; Department of Urology, Vanderbilt University Medical Center, Nashville, TN, USA.
Yukihiro K; Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Sentani K; Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Goto K; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Inoue S; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Ohara S; Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Teishima J; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Kajiwara M; Department of Urology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Nishisaka T; Department of Pathology, Hiroshima Prefectural Hospital, Hiroshima, Japan.
Yasui W; Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Black PC; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Matsubara A; Department of Urology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.
Pokaż więcej
Źródło :
BJU international [BJU Int] 2021 Apr; Vol. 127 (4), pp. 473-485. Date of Electronic Publication: 2020 Sep 21.
Typ publikacji :
Journal Article
MeSH Terms :
Progression-Free Survival*
Urinary Bladder Neoplasms/*classification
Urinary Bladder Neoplasms/*surgery
Aged ; Female ; Humans ; Male ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Retrospective Studies ; Risk Assessment ; Urinary Bladder Neoplasms/diagnosis ; Urinary Bladder Neoplasms/epidemiology
Czasopismo naukowe
Tytuł :
Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.
Autorzy :
Qu XM; London Health Sciences Centre, London, Canada; Schulich School of Medicine & Dentistry, Western University, London, Canada.
Chen Y; Schulich School of Medicine & Dentistry, Western University, London, Canada.
Zaric GS; Schulich School of Medicine & Dentistry, Western University, London, Canada; Ivey Business School, Western University, London, Canada.
Senan S; Amsterdam University Medical Center, Vrije Universiteit Medical Center, Amsterdam, Netherlands.
Olson RA; British Columbia Cancer, Centre for the North, Prince George, Canada.
Harrow S; Beatson West of Scotland Cancer Centre, Glasgow, Scotland.
John-Baptiste A; London Health Sciences Centre, London, Canada; Schulich School of Medicine & Dentistry, Western University, London, Canada.
Gaede S; London Health Sciences Centre, London, Canada.
Mulroy LA; Nova Scotia Cancer Centre, Halifax, Canada.
Schellenberg D; British Columbia Cancer, Surrey Centre, Surrey, Canada.
Senthi S; Alfred Health Radiation Oncology, Melbourne, Australia.
Swaminath A; Juravinski Cancer Centre, Hamilton, Canada.
Kopek N; McGill University Health Centre, Montreal, Canada.
Liu M; British Columbia Cancer, Vancouver Centre, Vancouver, Canada.
Warner A; London Health Sciences Centre, London, Canada.
Rodrigues GB; London Health Sciences Centre, London, Canada; Schulich School of Medicine & Dentistry, Western University, London, Canada.
Palma DA; London Health Sciences Centre, London, Canada; Schulich School of Medicine & Dentistry, Western University, London, Canada.
Louie AV; London Health Sciences Centre, London, Canada; Schulich School of Medicine & Dentistry, Western University, London, Canada; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Apr 01; Vol. 109 (5), pp. 1176-1184. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Progression-Free Survival*
Quality-Adjusted Life Years*
Neoplasms/*radiotherapy
Radiosurgery/*economics
Antineoplastic Agents/economics ; Canada ; Clinical Trials as Topic ; Cost-Benefit Analysis ; Disease Progression ; Female ; Humans ; Male ; Markov Chains ; Neoplasm Metastasis/drug therapy ; Neoplasm Metastasis/radiotherapy ; Neoplasms/drug therapy ; Neoplasms/mortality ; Neoplasms/pathology ; Radiosurgery/adverse effects ; Randomized Controlled Trials as Topic ; United States
Czasopismo naukowe
Tytuł :
Association between CT-Quantified Body Composition and Recurrence, Survival in Nonmetastasis Colorectal Cancer Patients Underwent Regular Chemotherapy after Surgery.
Autorzy :
Ying P; Department of Pneumology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jin W; Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Wu X; Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Cai W; Department of Gastroenterology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2021 Mar 25; Vol. 2021, pp. 6657566. Date of Electronic Publication: 2021 Mar 25 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Body Composition*
Progression-Free Survival*
Tomography, X-Ray Computed*
Colorectal Neoplasms/*diagnostic imaging
Colorectal Neoplasms/*surgery
Neoplasm Recurrence, Local/*diagnostic imaging
Colorectal Neoplasms/drug therapy ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Nomograms
Czasopismo naukowe
Tytuł :
Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
Autorzy :
Hada, Taira (AUTHOR)
Miyamoto, Morikazu (AUTHOR)
Ishibashi, Hiroki (AUTHOR)
Matsuura, Hiroko (AUTHOR)
Sakamoto, Takahiro (AUTHOR)
Kakimoto, Soichiro (AUTHOR)
Iwahashi, Hideki (AUTHOR)
Tsuda, Hitoshi (AUTHOR)
Takano, Masashi (AUTHOR)
Pokaż więcej
Źródło :
Journal of Ovarian Research. Dec2021, Vol. 14 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł :
Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
Autorzy :
Lu, Guang (AUTHOR)
Lu, Zhiwen (AUTHOR)
Li, Caixia (AUTHOR)
Huang, Xianping (AUTHOR)
Luo, Qiang (AUTHOR)
Pokaż więcej
Źródło :
Computational & Mathematical Methods in Medicine. 11/3/2021, p1-13. 13p.
Czasopismo naukowe
Tytuł :
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort.
Autorzy :
Cedres, Susana (AUTHOR)
Assaf, Juan-David (AUTHOR)
Iranzo, Patricia (AUTHOR)
Callejo, Ana (AUTHOR)
Pardo, Nuria (AUTHOR)
Navarro, Alejandro (AUTHOR)
Martinez-Marti, Alex (AUTHOR)
Marmolejo, David (AUTHOR)
Rezqallah, Alejandra (AUTHOR)
Carbonell, Caterina (AUTHOR)
Frigola, Joan (AUTHOR)
Amat, Ramon (AUTHOR)
Pedrola, Anna (AUTHOR)
Dienstmann, Rodrigo (AUTHOR)
Felip, Enriqueta (AUTHOR)
Pokaż więcej
Źródło :
Scientific Reports. 11/1/2021, Vol. 11 Issue 1, p1-10. 10p.
Czasopismo naukowe
Tytuł :
Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.
Autorzy :
Chen, Yen-Cheng (AUTHOR)
Tsai, Hsiang-Lin (AUTHOR)
Li, Ching-Chun (AUTHOR)
Huang, Ching-Wen (AUTHOR)
Chang, Tsung-Kun (AUTHOR)
Su, Wei-Chih (AUTHOR)
Chen, Po-Jung (AUTHOR)
Yin, Tzu-Chieh (AUTHOR)
Huang, Chun-Ming (AUTHOR)
Wang, Jaw-Yuan (AUTHOR)
Pokaż więcej
Źródło :
PLoS ONE. 11/2/2021, Vol. 16 Issue 11, p1-19. 19p.
Czasopismo naukowe
Tytuł :
Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement.
Autorzy :
Rosen, Jurij (AUTHOR)
Stoffels, Gabriele (AUTHOR)
Lohmann, Philipp (AUTHOR)
Bauer, Elena K. (AUTHOR)
Werner, Jan-Michael (AUTHOR)
Wollring, Michael (AUTHOR)
Rapp, Marion (AUTHOR)
Felsberg, Jörg (AUTHOR)
Kocher, Martin (AUTHOR)
Fink, Gereon R. (AUTHOR)
Langen, Karl-Josef (AUTHOR)
Galldiks, Norbert (AUTHOR)
Pokaż więcej
Źródło :
Scientific Reports. 10/21/2021, Vol. 11 Issue 1, p1-9. 9p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies